Compugen | CGEN - Equity Capital And Reserves


Compugen reported $43.83M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Arca Biopharma USD 486.79M 143.15M Sep/2025
aTyr Pharma USD 80.24M 5.58M Sep/2025
Bio Path USD -7.16M 4.57M Jun/2025
Brainstorm Cell Therapeutics USD -7.69M 1.64M Sep/2025
Cara Therapeutics USD 32.93M 41M Jun/2025
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 43.83M 6.43M Sep/2025
Immunic USD 10.5M 23.41M Sep/2025
Infinity Pharmaceuticals USD -37.41M 9.08M Jun/2023
Minerva Neurosciences USD -140.75M 106.17M Dec/2025
RedHill Biopharma USD -4.41M 271K Jun/2025
TherapeuticsMD USD 27.67M 990K Jun/2024